SEI Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.36M Sell
71,412
-9,697
-12% -$974K 0.01% 1223
2026
Q1
$7.49M Buy
81,109
+35,031
+76% +$3.3M 0.01% 1288
2025
Q4
$3.64M Buy
46,078
+30,474
+195% +$2.19M ﹤0.01% 1535
2025
Q3
$1.14M Buy
15,604
+6,902
+79% +$439K ﹤0.01% 1919
2025
Q2
$443K Sell
8,702
-5,209
-37% -$232K ﹤0.01% 2239
2025
Q1
$627K Buy
13,911
+1,797
+15% +$84.7K ﹤0.01% 2069
2024
Q4
$501K Sell
12,114
-4,576
-27% -$191K ﹤0.01% 2186
2024
Q3
$651K Buy
+16,690
New +$666K ﹤0.01% 2088
2022
Q3
Sell
-22,337
Closed -$435K 2697
2022
Q2
$435K Buy
+22,337
New +$527K ﹤0.01% 2159

Other funds holding MIRM

SEI Investments's MIRM Position: Q2 2026 in Review

SEI Investments reduced its Mirum Pharmaceuticals (MIRM) stake by 12% in Q2 2026, selling an estimated $974K and leaving 71,412 shares worth $8.36M. The position accounts for 0.01% of the portfolio, ranked #1223.

SEI Investments first reported a position in MIRM in Q2 2022 and has held it in 9 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • SEI Investments held 71,412 shares of Mirum Pharmaceuticals worth $8.36M as of Q2 2026.
  • SEI Investments sold 9,697 Mirum Pharmaceuticals shares in Q2 2026, an estimated $974K.
  • Mirum Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1223 holding.
  • SEI Investments first reported a position in Mirum Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.